In the recent years Milray JSC has involved in the conducted clinical trials more than 3 500 patients and 3 000 volunteers at more than 150 clinical sites, while establishing a network of more than 250 Principal Investigators. We are confident this pool of available expertise is both valuable and indicative of our efforts to foster a lasting synergy with a number of much-sought KOLs with a view of advancing the data quality even further to the benefit of the trials conducted.
Our experience spans mainly across the following therapeutic areas :
- Traumatology and orthopedics
- Allergology
- Otolaryngology
- Dermatology
- Neurology
- Oncology
- Chronic Renal failure (Haemodyalisis)
- Endocrinology and Metabolism
- Rheumatology
| Phase | Number of Projects |
|---|---|
| Phase I | 1 |
| Phase II | 1 |
| Phase III | 31 |
| Phase IV | 1 |
| BE/BA trials | 150 |
